#Drugrepurposing
LightNews LightNews
sdawsonberlin.bsky.social
Congratulations to the whole REPO4EU consortium! The beta #DrugRepurposing platform looks amazing.
September 23, 2026 at 10:03 AM
nintscheke.bsky.social
So excited to finally see it all come together!
The One-stop-shop for #drugrepurposing, #systemsmedicine, and #networkmedicine.

#repo4.eu platform kick-off in beta live at the #rexpo26 😎🎉
scienceopen.bsky.social ScienceOpen @scienceopen.bsky.social · 2d
#RExPO26Live #RExPO26

We welcome Balázs Orban & Dániel János Dallos from Egnosis, now live on stage!

💬 We look forward to Balázs Orban's & Dániel János Dallos's talk: "The REPO4EU Platform Beta Release: From Scientific Needs to Integrated Solutions"

📢 Thank you to everyone joining us!
September 23, 2026 at 9:35 AM
alexvespi.bsky.social
New computational package for #NetworkMedicine- %DiseaseModules, #DrugRepurposing and more:
PDF at barabasi.com/science/public…
GitHub :github.com/menicgiulia/Ne…
December 2, 2024 at 3:52 PM
drjudystone.bsky.social
The FDA needs comments telling it to focus on #InfectiousDisease for #DrugRepurposing, not low testosterone, and to support its available platform for doing so, CURE ID
www.federalregister.gov/documents/20...

Please boost! June 11 deadline
June 9, 2026 at 5:16 PM
castltrastondrs.medsky.network
#Medsky🧪 #IDSky #Drugrepurposing #pharmSky #SkyRx after almost two decades of the clinical use of GLP-1 for T2D & 10 years after the first GLP-1 , liraglutide, was approved for weight loss in people with obesity,
Mechanisms of actions
December 23, 2024 at 6:56 AM
drkristina.bsky.social
So excited to showcase my postdoctoral work today at #AACR25 !!! #drugrepurposing #bioassay #earlydrugdiscovery #cancerresearch @pblsanchis.bsky.social @greisha-ortiz.bsky.social @drkatiec.bsky.social @theaacr.bsky.social
April 28, 2025 at 6:49 PM
djmarsh24.bsky.social
Comprehensive review out in December's Biomedicine & Pharmacotherapy from postdoc in my group @amanialghalayini.bsky.social - #GynaecologicalCancer #DrugRepurposing #GynaeCancers #OvarianCancer #EndometrialCancer #Organoids #3Rs #ClinicalTrials & more!! 🧪 www.sciencedirect.com/science/arti...
Drug repurposing in gynaecological cancers: Proven drugs for new challenges
Gynaecological malignancies, including cervical, endometrial, ovarian, vaginal and vulval cancers, pose therapeutic challenges that contribute to this…
www.sciencedirect.com
December 8, 2025 at 4:20 AM
drjudystone.bsky.social
Michael Lewis is one hell of a writer--here on the FDA, Balamuthia, and #RareDiseases... Proud mama moment, forgive me. Gift link: wapo.st/3DELV80 #MedicalMysteries #Balamuthia #GorgasCourse #FDA #DrugRepurposing
wapo.st
March 13, 2025 at 2:27 PM
drjudystone.bsky.social
Important article on #DrugRepurposing and #Pharma greed blocking studies. #LongCovid
postviraltrials.bsky.social Post-Viral Trials @postviraltrials.bsky.social · Feb 20
Really upsetting stunning article where Avi Nath goes on the record with the names of people at Merck and Bristol Myers Squibb who denied him drugs to test his immune checkpoint inhibitor theory of Long Covid. Post-viral illness still has a serious image problem. cen.acs.org/pharmaceutic...
Long COVID studies stymied by pharma’s lack of cooperation
Academic researchers want to repurpose drugs for the condition. Manufacturers aren’t supplying them
cen.acs.org
February 21, 2025 at 9:14 PM
drjudystone.bsky.social
Congratulations to @cureid.bsky.social @idepiheather.bsky.social (Heather Stone) and team for publication: CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic Disorders
onlinelibrary.wiley.com/doi/10.1002/...
#DrugRepurposing #RareDisease
onlinelibrary.wiley.com
January 7, 2026 at 11:26 PM
drjudystone.bsky.social
New post: FDA Shows Growing Interest In Drug Repurposing And Seeks Public Comment

open.substack.com/pub/boosters... #DrugRepurposing
FDA Shows Growing Interest In Drug Repurposing And Seeks Public Comment
But some of their focus seems...odd
open.substack.com
June 9, 2026 at 1:36 AM
sdawsonberlin.bsky.social
Exciting to be at the #RExPO26 #drugrepurposing conference and see the cool updates to the #RepoScope database www.hmpharmacon.com/2021/05/08/r...
REPOSCOPE – The Landscape of Current Drug Repurposing Opportunities – H. M. Pharmacon
H.M. Pharma Consultancy is a service provider, but we are scientists at heart - and database builders. This allows us to see opportunities that others miss.
www.hmpharmacon.com
September 23, 2026 at 7:44 AM
repo4eu.bsky.social
Help us shape the future of #DrugRepurposing 💊

Our partners from @egnosis.bsky.social are looking for scientists, clinicians, bioinformaticians & regulatory experts to test the Alpha version of our online platform.

Find out more 👉 tally.so/r/3XjAbd

🇪🇺 #HorizonEU @scienceinnovation.ec.europa.eu
October 7, 2025 at 2:37 PM
remedi4all.bsky.social
REMEDi4ALL is a #HorizonEU research initiative to drive forward the repurposing of medicines in Europe. The project, has the potential to reduce times & costs of drug development, making drug repurposing the new normal.

👉 More here: remedi4all.org

#REMEDi4ALL #DrugRepurposing
December 17, 2024 at 9:50 AM
repo4eu.bsky.social
"Interdisciplinary collaboration is at the core of #RExPO26", says conference co-chair @hhhwschmidt.bsky.social

Join us to exchange knowledge and ideas on how we can collectively advance #PrecisionMedicine through #DrugRepurposing 👉 repo4.eu/rexpo26/

See you in Berlin next week 💊
September 16, 2026 at 3:06 PM
castltrastondrs.medsky.network
#MedSky🧪 #IDSky #ImmunoSky #Publichealth #PharmSky #SkyRx #RxSky #Drugrepurposing Recap : The management of the #COVID19pandemic has become increasingly challenging due to the emergence of several #SARSCoV2 variants that demonstrate increased transmissibility and resistance to vaccines & treatments
November 9, 2024 at 10:52 PM
repo4eu.bsky.social
#RExPO25 Speakers | S7: AI/ML in #SystemsMedicine & #DrugRepurposing

🟣 @itisalist.bsky.social & Lisa Spindler (@daisybio.de)

🟣 Jan Baumbach & Fernando Delgado Chavez (@cosybio-uhh.bsky.social)

Check the full conference agenda ⤵️
repo4.eu/rexpo25/agen...

🇪🇺 #EUfunded #DrugRepurposing
RExPO25 Session in focus: AI/ML in systems medicine and drug repurposing.
September 3, 2025 at 10:31 AM
scienceopen.bsky.social
'AI-Mind: Revolutionizing Personalized #Neurology Through Automated #Diagnostics and Advanced #Data Management' - an @repo4eu.bsky.social #DrugRepurposing article on #ScienceOpen: drugrepocentral.scienceopen.com/hosted-docum...
AI-Mind: Revolutionizing Personalized Neurology Through Automated Diagnostics and Advanced Data Management
drugrepocentral.scienceopen.com
May 27, 2025 at 12:28 PM
repo4eu.bsky.social
Check out the latest study conducted by #REPO4EU researchers 💊 'Navigating the Computational Landscape for #DrugRepurposing'

Published by @annualreviews.bsky.social ➡️ annualreviews.org/content/jour...

@upm.es @neurologieessen.bsky.social @maastrichtu.bsky.social

#EUfunded #EU4Health #HaDEA
New research paper: Navigating the computational landscape for drug repurposing.
January 26, 2026 at 4:23 PM
repo4eu.bsky.social
Hello Bluesky! Let us introduce ourselves 👉 we're REPO4EU, a #EUfunded project made out of 28 partners working together to advance #DrugRepurposing for #PrecisionMedicine in Europe and beyond 💊 🇪🇺 🌍

If you're into #NetworkMedicine, #PharmaInnovation and #AIinHealthcare, let's connect! 🔄

🌐 repo4.eu
REPO4EU Consortium celebrating the 3rd General Assembly (Stockholm, November 2023).
November 19, 2024 at 7:07 PM
castltrastondrs.medsky.network
#Medsky🧪 #IDsky #pharmasky #rxsky #immunosky #drugrepurposing A summarize the evidences from RCT on efficacy & safety of the various #COVID19 antivirals & discuss unmet needs which should be addressed…

journals.asm.org/doi/full/10....
COVID-19 therapeutics | Clinical Microbiology Reviews
SUMMARYSince the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options has been studied and deployed. Healthcare providers have multiple treatment approaches to choose from, but...
journals.asm.org
March 2, 2025 at 5:04 AM
drjudystone.bsky.social
I'm curious why the Federal Register is sitting on comments--not showing the number increasing and delaying publishing them.
www.federalregister.gov/documents/20...

Please tell the FDA to prioritize CURE ID’s work and infections for their #DrugRepurposing

The deadline for comments is June 11.
June 2, 2026 at 12:55 AM
repo4eu.bsky.social
Did you know we've launched our very own #OpenAccess Journal for the #DrugRepurposing research community? 💊

Check it out via @scienceopen.bsky.social 👉 drugrepocentral.scienceopen.com/collection/D...

@sdawsonberlin.bsky.social @nintscheke.bsky.social @hhhwschmidt.bsky.social @phdvoice.bsky.social
Drug Repurposing
<p>An Open Access journal for the Drug Repurposing community</p>
drugrepocentral.scienceopen.com
December 3, 2024 at 2:16 PM
remedi4all.bsky.social
Day 2 of #iDR25 is in full swing! We're tackling #DrugRepurposing, AI, #ClinicalTrial innovation, #PatientSccess, & more.

📸 Daria Julkowska, @erdera.bsky.social: “ #ERDERA aims to deliver real health gains for #RareDisease patients in the next decade.” #DrugRepurposing
May 8, 2025 at 12:53 PM
repo4eu.bsky.social
This figure illustrates that #drugrepurposing must be seen from a global perspective and is the reason why the #European platform project @REPO4EU has been reaching out globally since day 1. BrighamWomens CuresWReach A*STAR Research University of Newcastle
March 23, 2024 at 8:41 AM